7,948 Shares in Colgate-Palmolive Company $CL Purchased by Sawyer & Company Inc

Sawyer & Company Inc acquired a new position in Colgate-Palmolive Company (NYSE:CL) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 7,948 shares of the company’s stock, valued at approximately $678,000.

A number of other hedge funds have also recently made changes to their positions in the stock. Cooper Financial Group increased its holdings in Colgate-Palmolive by 4.0% in the 2nd quarter. Cooper Financial Group now owns 2,947 shares of the company’s stock valued at $270,000 after purchasing an additional 114 shares during the last quarter. Gould Capital LLC lifted its stake in Colgate-Palmolive by 38.7% during the first quarter. Gould Capital LLC now owns 412 shares of the company’s stock worth $35,000 after purchasing an additional 115 shares in the last quarter. Redhawk Wealth Advisors Inc. lifted its stake in Colgate-Palmolive by 2.8% during the second quarter. Redhawk Wealth Advisors Inc. now owns 4,326 shares of the company’s stock worth $397,000 after purchasing an additional 118 shares in the last quarter. SVB Wealth LLC boosted its position in shares of Colgate-Palmolive by 1.4% during the second quarter. SVB Wealth LLC now owns 8,767 shares of the company’s stock worth $804,000 after buying an additional 119 shares during the period. Finally, Sowell Financial Services LLC boosted its position in shares of Colgate-Palmolive by 2.1% during the third quarter. Sowell Financial Services LLC now owns 5,737 shares of the company’s stock worth $490,000 after buying an additional 119 shares during the period. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Down 1.1%

Colgate-Palmolive stock traded down $1.02 during mid-day trading on Wednesday, reaching $93.52. 1,254,343 shares of the company’s stock were exchanged, compared to its average volume of 5,641,868. The company has a market cap of $74.55 billion, a P/E ratio of 37.12, a P/E/G ratio of 4.52 and a beta of 0.33. Colgate-Palmolive Company has a twelve month low of $74.54 and a twelve month high of $99.33. The company has a quick ratio of 0.67, a current ratio of 1.03 and a debt-to-equity ratio of 13.82. The company has a fifty day moving average of $89.10 and a 200-day moving average of $89.17.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, July 31st. The company reported $0.99 EPS for the quarter, beating the consensus estimate of $0.95 by $0.04. The company had revenue of $5.36 billion during the quarter, compared to analysts’ expectations of $5.36 billion. Colgate-Palmolive had a net margin of 9.68% and a return on equity of 464.63%. The firm’s revenue was up 4.9% compared to the same quarter last year. During the same quarter last year, the company posted $0.92 EPS. Sell-side analysts expect that Colgate-Palmolive Company will post 3.87 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Tuesday, October 20th will be issued a $0.53 dividend. The ex-dividend date is Tuesday, October 20th. This represents a $2.12 dividend on an annualized basis and a yield of 2.3%. Colgate-Palmolive’s dividend payout ratio (DPR) is 84.13%.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, CEO Noel R. Wallace sold 161,021 shares of the stock in a transaction dated Tuesday, August 4th. The stock was sold at an average price of $91.92, for a total value of $14,801,050.32. Following the sale, the chief executive officer owned 362,231 shares of the company’s stock, valued at $33,296,273.52. This trade represents a 30.77% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director John T. Cahill sold 4,170 shares of the stock in a transaction dated Thursday, August 6th. The shares were sold at an average price of $93.37, for a total value of $389,352.90. Following the completion of the sale, the director directly owned 28,373 shares in the company, valued at $2,649,187.01. This represents a 12.81% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 175,191 shares of company stock worth $16,110,903. Company insiders own 0.43% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently weighed in on CL. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $104.00 price objective on shares of Colgate-Palmolive in a research note on Tuesday, September 8th. TD Cowen increased their target price on Colgate-Palmolive from $85.00 to $90.00 and gave the stock a “hold” rating in a research note on Monday, August 3rd. BNP Paribas Exane lowered their target price on Colgate-Palmolive from $101.00 to $97.00 and set an “outperform” rating for the company in a report on Monday, September 28th. JPMorgan Chase & Co. lifted their target price on Colgate-Palmolive from $103.00 to $104.00 and gave the company an “overweight” rating in a research report on Monday. Finally, Wells Fargo & Company cut their price target on shares of Colgate-Palmolive from $95.00 to $90.00 and set an “equal weight” rating on the stock in a research note on Monday, October 5th. Thirteen investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $98.00.

About Colgate-Palmolive

Colgate-Palmolive Company (NYSE: CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwash, liquid hand soap, body wash, deodorants, household cleaning products and pet food and treats.

The company markets well-known brands such as Colgate, Palmolive, elmex, meridol, Softsoap, Irish Spring, Ajax, Protex and Hill’s Science Diet. Colgate-Palmolive also provides veterinary and nutritional products through Hill’s Pet Nutrition, which serves pet owners and animal health professionals.

Founded in 1806 by William Colgate, the company developed from a soap and candle business into a diversified consumer goods manufacturer.